Medical Crossfire® in Adjunctive Testing: Charting a New Course in Prostate Cancer Risk Assessment
View More
FDA approves durvalumab/chemo for muscle–invasive bladder cancer
FDA approves expanded label for 177Lu-PSMA-617 in mCRPC
FDA grants marketing authorization to at-home diagnostic test for STIs
NeuroSAFE procedure for RARP leads to improved erectile function
